Penetration of Sulbactam and Ampicillin into Cerebrospinal Fluid of Infants and Young Children with Meningitis

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1987 Nov 1

PMID 3435118

Citations 10

Authors

G Foulds

T J McBRIDE

A K Knirsch

W J Rodriguez

W N Khan

Affiliations

Soon will be listed here.

Abstract

Infusions of 50 mg of sulbactam per kg per day and 400 mg of ampicillin per kg per day in divided doses to infants and children with bacterial meningitis produced levels in cerebrospinal fluid approximately one-third those in serum. Concentrations in cerebrospinal fluid of 5.5 micrograms of sulbactam per ml and 16.0 micrograms of ampicillin per ml declined within a few days of therapy to 1.9 microgram of sulbactam per ml and 5.2 micrograms of ampicillin per ml.

Citing Articles

Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis.

Bradley J, Bulitta J, Cook R, Yu P, Iwamoto C, Hesse E Clin Infect Dis. 2024; 78(6):1451-1457.

PMID: 38412060 PMC: 11175673. DOI: 10.1093/cid/ciae093.

Ampicillin/Sulbactam Treatment Modulates NMDA Receptor NR2B Subunit and Attenuates Neuroinflammation and Alcohol Intake in Male High Alcohol Drinking Rats.

Alasmari F, Alhaddad H, Wong W, Bell R, Sari Y Biomolecules. 2020; 10(7).

PMID: 32664441 PMC: 7407831. DOI: 10.3390/biom10071030.

Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy.

Wang Q, Wu Y, Chen B, Zhou J BMC Anesthesiol. 2015; 15:33.

PMID: 25798070 PMC: 4369365. DOI: 10.1186/s12871-015-0012-1.

Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Sullins A, Abdel-Rahman S Paediatr Drugs. 2013; 15(2):93-117.

PMID: 23529866 DOI: 10.1007/s40272-013-0017-5.

Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Nau R, Sorgel F, Eiffert H Clin Microbiol Rev. 2010; 23(4):858-83.

PMID: 20930076 PMC: 2952976. DOI: 10.1128/CMR.00007-10.

References

Tomeh M, Starr S, McGowan Jr J, Terry P, Nahmias A . Ampicillin-resistant Haemophilus influenzae type B infection. JAMA. 1974; 229(3):295-7. View

Thornsberry C, Kirven L . Antimicrobial susceptibility of Haemophilus influenzae. Antimicrob Agents Chemother. 1974; 6(5):620-4. PMC: 444703. DOI: 10.1128/AAC.6.5.620. View

Nelson J . Editorial: Should ampicillin be abandoned for treatment of Haemophilus influenzae disease?. JAMA. 1974; 229(3):322-4. View

English A, Retsema J, GIRARD A, LYNCH J, Barth W . CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. Antimicrob Agents Chemother. 1978; 14(3):414-9. PMC: 352474. DOI: 10.1128/AAC.14.3.414. View

Aswapokee N, Neu H . A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor. J Antibiot (Tokyo). 1978; 31(12):1238-44. DOI: 10.7164/antibiotics.31.1238. View

Labia R, Lelievre V, Peduzzi J . Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899). Biochim Biophys Acta. 1980; 611(2):351-7. DOI: 10.1016/0005-2744(80)90071-6. View

Wise R, Andrews J, Bedford K . Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins. J Antimicrob Chemother. 1980; 6(2):197-206. DOI: 10.1093/jac/6.2.197. View

Retsema J, English A, GIRARD A . CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides. Antimicrob Agents Chemother. 1980; 17(4):615-22. PMC: 283841. DOI: 10.1128/AAC.17.4.615. View

Brown R, Wise R, Andrews J, Hancox J . Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration. Antimicrob Agents Chemother. 1982; 21(4):565-7. PMC: 181942. DOI: 10.1128/AAC.21.4.565. View

10.

Foulds G, Stankewich J, Marshall D, OBrien M, Hayes S, Weidler D . Pharmacokinetics of sulbactam in humans. Antimicrob Agents Chemother. 1983; 23(5):692-9. PMC: 184789. DOI: 10.1128/AAC.23.5.692. View

11.

Rogers H, Bradbrook I, Morrison P, Spector R, Cox D, Lees L . Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography. J Antimicrob Chemother. 1983; 11(5):435-45. DOI: 10.1093/jac/11.5.435. View

12.

Istre G, CONNER J, Glode M, Hopkins R . Increasing ampicillin-resistance rates in Hemophilus influenzae meningitis. Am J Dis Child. 1984; 138(4):366-9. DOI: 10.1001/archpedi.1984.02140420032012. View

13.

Schlech 3rd W, Ward J, Band J, Hightower A, Fraser D, Broome C . Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA. 1985; 253(12):1749-54. View

14.

Foulds G, Knirsch A, Stankewich J, Weidler D . The parenteral kinetics of ampicillin/sulbactam in man. Int J Clin Pharmacol Res. 1985; 5(2):79-86. View

15.

Stephenson W, Doern G, Gantz N, Lipworth L, Chapin K . Pharyngeal carriage rates of Haemophilus influenzae, type b and non-b, and prevalence of ampicillin-resistant Haemophilus influenzae among healthy day-care children in central Massachusetts. Am J Epidemiol. 1985; 122(5):868-75. DOI: 10.1093/oxfordjournals.aje.a114169. View

16.

Whitby M, Finch R . Bacterial meningitis. Rational selection and use of antibacterial drugs. Drugs. 1986; 31(3):266-78. DOI: 10.2165/00003495-198631030-00004. View

17.

Retsema J, English A, Girard A, LYNCH J, Anderson M, Brennan L . Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. Rev Infect Dis. 1986; 8 Suppl 5:S528-34. DOI: 10.1093/clinids/8.supplement_5.s528. View

18.

Hanninen P, Rossi T . Penetration of sulbactam into cerebrospinal fluid of patients with viral meningitis or without meningitis. Rev Infect Dis. 1986; 8 Suppl 5:S609-11. DOI: 10.1093/clinids/8.supplement_5.s609. View

19.

Stahl J, Bru J, Fredj G, BRAMMER K, Malleret M, MICOUD M . Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapy. Rev Infect Dis. 1986; 8 Suppl 5:S612-6. DOI: 10.1093/clinids/8.supplement_5.s612. View

20.

Rodriguez W, Khan W, Puig J, Feris J, Harmon S, Gold B . Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children. Rev Infect Dis. 1986; 8 Suppl 5:S620-9. DOI: 10.1093/clinids/8.supplement_5.s620. View